← Leaderboards
Sarah Linnstaedt
Univ Of North Carolina Chapel Hill
$3,130,037
Attributed
$4,807,228
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,807,228 · 3
By mechanism
R01$4,304,794 · 2
K01$502,434 · 1
Top collaborators
- Samuel A. Mclean3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Samuel Arbes$42,437,176
- Inna Evgenievna Tchivileva$1,235,635
- Susan S. Girdler$23,118,529
- Matthew Christopher Mauck$4,422,436
- Nathaniel A. Hathaway$4,359,744
Others in their field
Other Emerging Leaders on “Pain”
- Abraham Aizer Brody · New York University School Of Medicine$25,530,786
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Barbara Burtness · Yale University$11,235,253
- William Russell Renthal · Brigham And Women'S Hospital$11,023,625
Research focus
PainPlayMediatingTranslational ResearchChronic PainAffectInjuryExposure ToSeveritiesMolecularVehicle CrashInfluentialsInsightAwardHypersensitivityInflammatoryExperimental StudyBiologicalCohortHyperalgesiaEnrollmentEstradiolAnimalsAnimal Model
Grant awards (9)
Sex-dependent microRNA-mediated pathways to chronic musculoskeletal pain following trauma$458,548
R01 · FY2025 · AR · contact PI
FKBP51 antagonism to prevent chronic pain: optimizing efficacy & evaluating safety and mechanisms$705,649
R01 · FY2024 · NS · contact PI
Sex-dependent microRNA-mediated pathways to chronic musculoskeletal pain following trauma$491,864
R01 · FY2024 · AR · contact PI
Diversity Supplement to FKBP51 antagonism to prevent chronic pain: optimizing efficacy & evaluating safety and mechanisms R01NS118563$59,081
R01 · FY2022 · NS · contact PI
Key Molecular Mechanisms of Chronic Pain Vulnerability in Women Experiencing MVC$125,629
K01 · FY2021 · AR · contact PI
FKBP51 antagonism to prevent chronic pain: optimizing efficacy & evaluating safety and mechanisms$2,589,652
R01 · FY2020 · NS · contact PI
Key Molecular Mechanisms of Chronic Pain Vulnerability in Women Experiencing MVC$125,629
K01 · FY2020 · AR · contact PI
Key Molecular Mechanisms of Chronic Pain Vulnerability in Women Experiencing MVC$125,588
K01 · FY2019 · AR · contact PI
Key Molecular Mechanisms of Chronic Pain Vulnerability in Women Experiencing MVC$125,588
K01 · FY2018 · AR · contact PI